Press launch content material from World Newswire. The AP news staff members was not associated in its generation.
Push launch content material from Globe Newswire. The AP information staff was not involved in its creation.
Traders can contact the regulation organization at no price tag to master much more about recovering their losses
LOS ANGELES, Jan. 12, 2021 (Globe NEWSWIRE) — The Portnoy Law Firm advises Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT) investors that the firm has initiated an investigation into feasible securities fraud, and may file a class action on behalf of investors.
Buyers are inspired to make contact with attorney Lesley F. Portnoy, by cellphone 310-692-8883 or e-mail: lesl[email protected], to examine their authorized legal rights, or click on in this article to be a part of the circumstance by means of www.portnoylaw.com. The Portnoy Legislation Organization can deliver a complimentary case analysis and go over investors’ possibilities for pursuing statements to recover their losses.
The investigation focuses on no matter whether Sarepta issued misleading and/or wrong statements and/or failed to disclose facts pertinent to investors. On January 7, 2021, it was introduced by Sarepta that its a single-time gene therapy for Duchenne muscular dystrophy experienced failed to demonstrate patient advantages in comparison to a placebo. On January 8, 2021, shares of Sarepta experienced a massive fall, primarily based on this information.
Make sure you pay a visit to our web page to review extra facts and post your transaction details.
The Portnoy Law Agency signifies traders in pursuing statements arising from corporate wrongdoing. The Firm’s founding spouse has recovered above $5.5 billion for aggrieved investors. Lawyer advertising and marketing. Prior success do not assurance equivalent results.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
Lawyer Advertising and marketing